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The use of mass spectrometry to study protein–ligand interactions is expanding into more
complex systems including protein–DNA interactions. The excess amount of a model DNA
or, more typically, an oligodeoxynucleotide (ODN), needed to study such interactions in
an amide hydrogen-deuterium (H/D) exchange experiment, for example, causes serious
signal suppression in the protein analysis. We describe here a modification of the
traditional H/D exchange protocol whereby we utilize a strong anion exchange column to
rapidly remove the ODN from solution before MS analysis. We showed the successful
incorporation of such a column in a study of two protein–ODN systems: (1) the
DNA-binding domain of human telomeric repeat binding factor 2 with a telomeric
oligodeoxynucleotide and (2) thrombin with the thrombin-binding aptamer. The approach
gave no appreciable difference in back-exchange compared to a method in which no strong
anion exchange (SAX) is used. (J Am Soc Mass Spectrom 2008, 19, 887–890) © 2008
American Society for Mass SpectrometryHydrogen-deuterium (H/D) exchange mass spec-trometry (MS) [1] is an emerging tool for study-ing protein–ligand interactions. Although the fi-
nal measurement is in the gas phase of a mass
spectrometer, H/D exchange enables the interactions to
be studied under “biologically relevant” solution condi-
tions (i.e., neutral pH, strong buffers, and high ionic
strengths) and at relatively low concentrations of protein.
The amide exchange is monitored by measuring the mass
change of a protein, in either a bound or unbound state,
after incubation in deuterated buffer. If amide sites are
affected by ligand binding, their exchange rates may
decrease in the bound state. Differences are caused by
global or local conformational changes associated with
ligand binding, formation of protein–ligand interfaces,
and/or formation of more stabilized secondary structure
elements throughout the protein. Both kinetics of ex-
change and affinity of the protein can be determined, the
latter by either PLIMSTEX (Protein–Ligand Interactions
by Mass Spectrometry, Titration, and H/D Exchange) [2]
or SUPREX (Stability ofUnpurified Proteins from Rates of
H/D Exchange) [3].
In many H/D exchange protocols, an aqueous pro-
tein solution is diluted with deuterated buffer to make
an exchange solution high in D2O content. After an
appropriate exchange time, the reaction is quenched by
lowering the pH to 2–3 and the temperature to near 0 °C.
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column and washed with chilled water (pH 2–3). The
wash step removes salts, buffers, and back-exchanges the
fast-exchanging deuterated sites. The protein is eluted into
the mass spectrometer, where its mass is measured to
reveal the extent of deuterium uptake. Ideally the steps
from quench to detection are sufficiently rapid (within
3 min) to ensure that few deuteria are lost to back-
exchange.
Although H/D exchange has been successfully ap-
plied to many protein–ligand interactions, there are few
reports of those involving an oligodeoxynucleotide
(ODN) [4, 5]. While investigating two protein–ODN
interactions using electrospray ionization (ESI), we dis-
covered that the protein signal can be entirely sup-
pressed by the presence of an ODN, especially when its
concentration exceeds that of the protein by a factor of
three or more. Given that ODN:protein ratios greater
than 10:1 are required to ensure nearly complete bind-
ing, a means of reducing the concentration of the ODN
before MS analysis is needed. One possibility is to add
ion-exchange chromatography; another is to change to
matrix-assisted laser desorption ionization (MALDI),
which is less susceptible to signal suppression [4].
Ion-exchange chromatography [6–8] separates species
based on their charge in solution. An anion-exchange
column should trap ODN anions but minimally affect
the protein cations, taking advantage that, under
quench conditions, the ODN is anionic and the protein
cationic. Here we describe the use of a dual-column
approach for H/D exchange of protein–ODN com-
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systems.
Experimental
Reagents
The sodium chloride (NaCl) salt, potassium chloride
(KCl) salt, HEPES buffer (N-2-hydroxyethylpipera-
zine-N=-2-ethanesulfonic acid and sodium salt), iso-
topically labeled water (D2O, 99.999% deuterium
replacement), formic acid, hydrochloric acid, and
acetonitrile reagents were purchased from Sigma-
Aldrich (St. Louis, MO, USA) at the highest purity
available and were used without further purification.
The -thrombin protein was purchased from Hema-
tologic Technologies Inc. (Essex Junction, VT, USA)
as a 167 M solution in 50% glycerol (aq) and was
stored at 4 °C upon receipt without further purifi-
cation. The thrombin-binding aptamer (5=-GGT TGG
TGT GGT TGG-3=) was purchased from Integrated
DNA Technologies (Coralville, IA, USA) as an am-
monium salt. This sample was purified by the man-
ufacturer using reverse-phase HPLC to exclude salts
as much as possible. The DNA-binding domain of
human telomeric repeat factor 2 (hTRF2) was pre-
pared as described previously [5]. The model of
telomeric DNA (5=-GTT AGG GTT AGG G-3=) and its
complement were also purchased from Integrated
DNA Technologies, analyzed by mass spectrometry
for purity, and used without further purification.
Model System
Thrombin interaction. The master solution of the throm-
bin-binding aptamer was prepared by dissolving
weighed amounts of solid sample in deionized water.
The master protein solution was prepared by diluting
the solution received from the manufacturer with
HEPES buffer solution. The concentrations of these
master solutions were determined by UV absorption
spectrophotometry; for each sample, a calibration plot
was prepared to give the molar absorptivity. For the
aptamer, the experimentally determined value agreed
to within 1% of the value calculated by the nearest-
neighbor method for the given sequence and agreed
with the molar absorptivity reported by the manufac-
turer. For the protein, the experimentally determined
value agreed to within 5% of the value reported by the
manufacturer. The “working master” apothrombin so-
lution was 2.5 M in 10 mM HEPES, pH 6.8, and
contained 25 mM NaCl and 0.8% glycerol (vol/vol),
whereas the “working master” holo solution was 2.5
M thrombin and 25 M thrombin-binding aptamer in
10 mM HEPES, pH 6.8, containing 25 mM NaCl and
0.8% glycerol (vol/vol).
Human TRF2 interaction. Double-stranded telomeric
DNA was prepared by mixing equimolar amounts ofthe complementary, single-stranded ODNs in a 10 mM
HEPES buffer containing 150 mM KCl. Duplex forma-
tion was monitored by UV absorption spectrophotom-
etry (260 nm) by decreasing the solution temperature
from 95 to 25 °C by 5 °C increments every 30 min. The
apo protein stock solution was prepared so that it
contained 41 M hTRF2 in 10 mM HEPES (pH 7.4) and
150 mM KCl. The holo protein stock solution was
prepared so that it contained 41 Mprotein and 410 M
telomeric DNA in 10 mM HEPES (pH 7.4) and 150 mM
KCl. The preparation of these samples was discussed
previously [5].
Mass Spectrometry
Mass spectra were acquired using a quadrupole-time of
flight (Q-ToF) Ultima mass spectrometer (Waters, Mil-
ford, MA, USA), equipped with an ESI source and
operated in the positive-ion mode. The instrument
conditions were optimized for each protein analyzed;
briefly, the capillary voltage was 3.0–3.2 kV, the cone-
voltage readback was 100–105 V, the cone-gas flow rate
was 40 L/h, the desolvation gas flow rate was 400 L/h,
the source temperature was 80 °C, and the desolvation
temperature was 180 °C. The MS profile used for quad-
rupole transmission was: from m/z 500, dwell for 5% of
the scan time, ramp tom/z 1000 for 45% of the scan time,
then dwell atm/z 1000 for the remaining 50% of the scan
time. The scan time for the instrument was 2 s. The
protein–ODN solution was passed through the
strong anion exchange (SAX) column (1  15 mm
OPTI-GUARD, Optimize Technologies Inc., Oregon
City, OR, USA), to trap the ODN, and then onto a C8
reverse-phase guard column (1  15 mm OPTI-
GUARD), pre-equilibrated with 0.2% formic acid in
water, to trap the protein. The reverse-phase column
was washed with 300 L of 0.2% formic acid in water
(0 °C) and eluted using an isocratic flow of 30% solvent
B (hTRF2) or 50% solvent B (thrombin) at 40 L/min by
a Waters CapLC. The HPLC solvents were (solvent A)
94.7% deionized water, 5% acetonitrile, and 0.3% formic
acid and (solvent B) 94.7% acetonitrile, 5% deionized
water, and 0.3% formic acid.
Results and Discussion
To minimize ionization suppression effects of an oli-
godeoxynucleotide (ODN) in protein studies, we con-
sidered capturing the protein on a reverse-phase col-
umn and washing away the ODN. Although such
gradient elution may be successful, its use increases the
experimental time and, consequently, the extent of
back-exchange. Further, a gradient elution approach
would not be amenable for studies in which the deu-
terated protein is proteolyzed to gain higher resolution
data because retention of the peptides formed in prote-
oloysis and ODN will be similar, thus creating the
potential for peptide-signal suppression. These disad-
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anion exchange (SAX) column to remove the ODN.
In the modified procedure, we placed the SAX column
in the flow path after the syringe injection port
and in front of the injection valve (see Figure 1). At the
start of an experiment, the injection valve was in LOAD
for injection of the protein–ODN mixture with a standard
syringe. The solution passed sequentially through the
SAX column, the injection loop, the reverse-phase column
(typically C8), and finally through the waste port of the
valve. Because the quenched solution’s pH is 2–3, the
protein remains positively charged, whereas the ODN is
negative. Therefore, the ODN adheres to the SAX column
while the protein passes on and is trapped on the reverse-
phase column. Having separated the ODN and protein
molecules, the protein is washed with chilled water (pH
2–3) and eluted isocratically into themass spectrometer by
switching the injector valve to INJECT. While in this
mode, the ODN was eluted from the SAX column with
300 L of aqueous NaOH (pH 9–10).
One model system to test the effectiveness of strong
anion exchange involves the 7.5 kDa DNA-binding do-
main of the hTRF2 that interacts with a double-stranded
telomeric ODN [5]. The second model is the thrombin-
thrombin binding aptamer where a 36 kDa protein inter-
acts with a single-stranded DNA aptamer that is folded
into a non-canonical quadruplex structure [9].
The mass spectrum (Figure 2a) is of 10 pmol of
hTRF2 injected onto a C8 column and eluted into the
mass spectrometer without the use of a SAX column.
That in Figure 2b, however, is of 10 pmol of hTRF2 with
100 pmol of telomeric ODN injected onto and eluted
from a C8 column without the use of a SAX column.
This 10:1 ratio ensured nearly complete binding of the
protein in solution. We observed no protein ions result-
ing from excessive ion suppression from the ODN.
Observed instead are the positive ions of the C-rich
strand of telomeric DNA (the ion at m/z 956.7 is the 4
charge state and the ion at m/z 1275.3 is the 3). When
we incorporated the SAX column and injected the same
10:1 sample, we found a significant increase in the
protein signal and no ions from the ODN (Figure 2c).
The relative intensity of the protein signal in Figure 2c
is 10–15% that of Figure 2a.
Turning to the second model, the control is a mass
spectrum (Figure 2d) of 10 pmol of thrombin loaded
onto a C8 column and eluted into the mass spectrometer
without a SAX column. That in Figure 2e, 10 pmol of
thrombin and 100 pmol of its ODN ligand loaded onto
a C8 column and eluted without a SAX column, shows
the dramatic signal suppression of the ODN. The ions
shown in Figure 2e are of the ODN ligand (the ion of
m/z 977.9 is the5 charge state and the ion ofm/z 1221.9
is the 4 charge state). The salutary effect of incorpo-
rating a SAX column for the analysis of the 10:1 sample
solution (Figure 2f) is revealed by an increase in the
relative abundance of the protein signal, which is
10–15% of the relative abundance of the protein signal
in Figure 2d.In the modified procedure, the time from quench to
detection is not increased so it is unlikely that back-
exchange is increased by inclusion of the SAX column.
To test our hypothesis, we measured the extent of D
uptake for a 1:1 mixture of hTRF2 and its ligand
(double-stranded telomeric DNA) in the presence and
absence of a SAX column. In this experiment, the
protein–ODN mixture was incubated in deuterated
buffer (97% D2O) for 10 min, quenched, loaded onto the
C8 column (with and without SAX), washed, and eluted
into the mass spectrometer. For triplicate experiments,
the average uptake without SAX was 53.2  0.9 Da,
whereas with SAX, the average was 53.7  0.9 Da.
Clearly, the presence of the SAX column does not affect
the extent of back-exchange.
Conclusion
In summary, the application of H/D exchange to protein–
ODN interactions requires decreasing the amount of sig-
nal suppression caused when the ODN coelutes with the
protein into the ESI mass spectrometer. The simple incor-
poration of a SAX column into the experimental protocol
enables trapping the ODN while passing most of the
protein onto a reverse-phase column and into the ion
source without increasing the extent of back-exchange.
Although we do not report here the outcome and inter-
pretation of the H/D exchange data, we can state that this
modified approach worked for two protein–ODN sys-
tems: a TRF2 interaction, where the H/D exchange results
were recently reported [5]; and a thrombin interaction,
where the H/D exchange study is the focus of current
Figure 1. Diagram of the dual-column setup in the load and
inject mode.work.
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